Tobramycin injection is an antibiotic and is indicated for the use in treating or preventing infections that are proven or strongly suspected to be caused by susceptible bacteria.
Arthur Przybyl, president and CEO of Akorn and member manager of Akorn-Strides, said: “We are excited to announce this product approval for tobramycin injection.”